Eli Lilly Enters $2 Billion Agreement for AI-Driven Drug Development with Hong Kong Biotech
Pharmaceutical giant Eli Lilly has announced a significant partnership with a biotechnology firm based in Hong Kong, entering into a deal valued at $2 billion aimed at advancing drug development…